Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Indian J Anaesth ; 67(6): 523-529, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37476444

ABSTRACT

Background and Aim: Spinal anaesthesia-induced hypotension (SAIH) is a frequent side effect of spinal anaesthesia. SAIH is usually observed in patients with hypovolemia. Ultrasonography has evolved as a non-invasive tool for volume status assessment. Methods: This prospective, blinded, observational study was conducted on 75 adult patients who required spinal anaesthesia after receiving ethical approval and registering the study. Ultrasonographic evaluation of the aorta and the inferior vena cava (IVC) was done preoperatively, and the IVC collapsibility index (IVCCI) and caval aorta index were calculated. The incidence of SAIH was recorded. The strength of the association between different parameters and SAIH was calculated. To find out the value of the optimal cut-off for the prediction of SAIH, receiver operating characteristic (ROC) analysis for various ultrasound parameters was done. The bidirectional stepwise selection was utilised for multivariate analysis to choose the single best predictor. Results: SAIH was observed in 36 patients. Among demographic parameters, age, female gender, and height showed a medium correlation. Among ultrasonographic measurements, minimum IVC internal diameter (IVCmin) and IVCCI showed a strong association with SAIH. The best parameter regarding area under the ROC curve (AUC) and diagnostic accuracy was IVCCI (0.828 and 85%, respectively). On multivariate analysis, age (95% CI [1.01, 1.12], P = 0.024) and IVCCI (95% CI [1.05, 1.18], P < 0.001) were significant independent predictors. At a cut-off point of ≥43.5%, IVCCI accurately predicted SAIH (sensitivity 81% and specificity 90%). Conclusion: Preoperative ultrasonographic assessment of IVC to evaluate its collapsibility index is a convenient, cost-effective, and reproducible tool for predicting SAIH.

3.
Elife ; 122023 02 23.
Article in English | MEDLINE | ID: mdl-36820519

ABSTRACT

Activation of voltage-gated calcium channels at presynaptic terminals leads to local increases in calcium and the fusion of synaptic vesicles containing neurotransmitter. Presynaptic output is a function of the density of calcium channels, the dynamic properties of the channel, the distance to docked vesicles, and the release probability at the docking site. We demonstrate that at Caenorhabditis elegans neuromuscular junctions two different classes of voltage-gated calcium channels, CaV2 and CaV1, mediate the release of distinct pools of synaptic vesicles. CaV2 channels are concentrated in densely packed clusters ~250 nm in diameter with the active zone proteins Neurexin, α-Liprin, SYDE, ELKS/CAST, RIM-BP, α-Catulin, and MAGI1. CaV2 channels are colocalized with the priming protein UNC-13L and mediate the fusion of vesicles docked within 33 nm of the dense projection. CaV2 activity is amplified by ryanodine receptor release of calcium from internal stores, triggering fusion up to 165 nm from the dense projection. By contrast, CaV1 channels are dispersed in the synaptic varicosity, and are colocalized with UNC-13S. CaV1 and ryanodine receptors are separated by just 40 nm, and vesicle fusion mediated by CaV1 is completely dependent on the ryanodine receptor. Distinct synaptic vesicle pools, released by different calcium channels, could be used to tune the speed, voltage-dependence, and quantal content of neurotransmitter release.


Subject(s)
Caenorhabditis elegans , Ryanodine Receptor Calcium Release Channel , Synaptic Vesicles , Animals , Caenorhabditis elegans/physiology , Calcium/metabolism , Neurotransmitter Agents/metabolism , Presynaptic Terminals/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Synaptic Transmission/physiology , Synaptic Vesicles/metabolism
4.
J Anaesthesiol Clin Pharmacol ; 38(2): 294-299, 2022.
Article in English | MEDLINE | ID: mdl-36171921

ABSTRACT

Background and Aims: The perfusion index (PI) has been used as a marker of peripheral perfusion. A lower PI indicates greater peripheral vascular tone and increased risk of hypotension following spinal anesthesia. The present study was conducted to evaluate and correlate perfusion index (PI) with incidence of hypotension following spinal anesthesia for caesarean section. Material and Methods: The present prospective, double blind, observational study included sixty full term parturients in the age group 18-35 years belonging to American Society of Anesthesiologists (ASA) physical status I and II, having singleton pregnancy undergoing caesarean section under spinal anesthesia. On the basis of baseline PI, patients were allocated into one of the two groups: Group I (n = 30) Patients with baseline PI ≤.3.5 and Group II (n = 30) Patients with PI >3.5. Results: The incidence of hypotension in group I was 40% as compared to 73.3% in group II (p = 0.009). Thus, the incidence of hypotension in group II with baseline PI >.3.5 was more as compared to group I. Patients in group II with baseline PI >.3.5 had significantly more episodes of hypotension as compared to those in group I with baseline PI ≤3.5. Conclusion: PI can be used as a useful tool for predicting hypotension in parturients undergoing elective caesarean section under spinal anesthesia in everyday practice.

5.
Cureus ; 14(6): e25767, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35812600

ABSTRACT

BACKGROUND: Perioperative airway changes due to anesthesia and surgery could change a normal airway at induction to a risky airway at extubation. OBJECTIVES: The objective is to evaluate primarily the degree of airway changes, as quantified by the modified Mallampati (MMP) class, after spine surgery in the prone position. Secondary to assess the time required for these changes to revert back to the preoperative state and their correlation with other demographic and surgical variables. METHODS: The present prospective observational study was conducted in a tertiary care hospital after ethical approval and trial registration. Fifty ASA I and II patients aged 18-65 years of both sex and undergoing spine surgery in prone positions were included. Supine MMP grade was observed preoperatively and at one, two, four, 24, and 48 hours postoperatively. STATISTICAL ANALYSIS: IBM SPSS version 22 (IBM Corp, Armonk, NY) was used.Mean values were compared using paired t-tests and medians by the Wilcoxon test. The Spearman correlation was used to assess a relationship. The time for recovery was analyzed by Kaplan-Meir analysis. RESULTS: An increase in MMP grade was observed at one hour postoperatively in 46 (92%) patients. Changes reverted back in 45 (98%) patients by 24 hours postoperatively. A weak positive correlation with age, weight, body mass index, duration of surgery, perioperative drop in hemoglobin, and a moderate positive correlation with fluid administered and estimated blood loss was recorded. CONCLUSIONS: An increase in postoperative MMP occurs in the majority of patients undergoing prone position spine surgery which may persist up to 48 hours. So, more vigilance and caution are warranted should reintubation be needed postoperatively.

6.
Cureus ; 14(5): e24685, 2022 May.
Article in English | MEDLINE | ID: mdl-35663704

ABSTRACT

Ischemic heart disease (IHD), also known as coronary artery disease, occurs due to the blockage of coronary arteries which reduces the blood supply of the myocardium. The main goal of the anesthetic management of IHD patients undergoing non-cardiac surgery is to maintain the balance between myocardial oxygen supply and demand. Here, we report the anesthetic management of an IHD patient with a low ejection fraction who was posted for percutaneous nephrolithotomy in the prone position. We opted for graded epidural anesthesia with a low dose of a local anesthetic drug and opioid. Graded epidural anesthesia is a safe alternative over general anesthesia for patients with IHD and low ejection fraction as it reduces stress response to surgery, provides good postoperative analgesia, and avoids myocardial depressant drugs and coagulation responses.

7.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 3): 5448-5453, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36742523

ABSTRACT

Laryngeal mirror (LM) is an inexpensive, portable, readily available device which can help visualize the vocal cords in difficult airway (DA) situations. We evaluated its use in improving glottic view prior to placing the airway adjuncts in simulated difficult airway.Eighty patients scheduled to undergo elective surgery under general anaesthesia with endotracheal intubation were allocated- Bougie group (Group B) and Stylet group (Group S). Direct laryngoscopy was performed and CL grade III simulated. The glottic view was obtained using laryngeal mirror and Gum Elastic Bougie (GEB)/ Styleted Endotracheal Tube (ETT) inserted under mirror view. Time taken to obtain glottic view in LM and time for successful intubation were noted.Significant improvement in glottic view with LM was observed, with the view improving to Grade I in 76.25% and grade II in 23.75% of patients. Both groups were comparable with respect to number of attempts and success rate (p = 0.55).The success rate was 90% in group B and 95% in group S. Time taken for intubation was less in Group S (52.44 ± 14.23 s vs. 62.805 ± 20.74 s) [p = 0.01]. Hence, overall stylet proved to be a better adjunct with mirror guided intubation.We recommend stylet assisted rather than GEB assisted ET intubation under LM guidance in emergency scenarios. Also, further controlled trials are recommended to know the exact location of the mirror in relation to bulb of the laryngoscope as well as different angles at which it is placed to improve the view and stabilize the assembly.

8.
Med Sci Sports Exerc ; 50(2): 344-352, 2018 02.
Article in English | MEDLINE | ID: mdl-28945675

ABSTRACT

PURPOSE: This study aimed to examine the effect of taurine ingestion on maximal voluntary muscle torque and power in trained male athletes with different caffeine habits. METHODS: Fourteen male athletes 21.8 ± 2.5 yr old were separated into caffeine and noncaffeine consumers to control for the effect of caffeine withdrawal on muscle function. On separate occasions, participants performed four isokinetic or three maximal isometric knee extensions with and without taurine (40 mg·kg body mass) after a double-blind, counterbalanced design. Muscle contractile performances were compared between the first sets as well as between the sets where these variables scored best. RESULTS: In response to isokinetic contraction, taurine treatment in the noncaffeine consumers resulted in a significant fall in first (-16.1%; P = 0.013) and best peak torque (-5.0%; P = 0.016) as well as in first (-17.7%; P = 0.015) and best power output (-8.0%; P = 0.008). In the caffeine consumers deprived of caffeine, taurine intake improved best power (5.2%; P = 0.045). With respect to the isometric variables, there was a significant decrease in the first (-5.1%; P = 0.002) and best peak torque (-4.3%; P = 0.032) in the noncaffeine group, but no effect in the group of caffeine consumers deprived of caffeine. Taurine ingestion increased blood taurine levels but had no effect on plasma amino acid levels. CONCLUSIONS: Taurine ingestion is detrimental to maximal voluntary muscle power and both maximal isokinetic and isometric peak torque in noncaffeine consumers, whereas taurine ingestion in caffeine-deprived caffeine consumers improves maximal voluntary muscle power but has no effect on other aspects of contractile performance.


Subject(s)
Muscle Contraction/drug effects , Muscle Strength/drug effects , Muscle, Skeletal/drug effects , Taurine/administration & dosage , Adult , Caffeine/administration & dosage , Double-Blind Method , Humans , Male , Muscle, Skeletal/physiology , Taurine/pharmacology , Torque , Young Adult
9.
Hiroshima J Med Sci ; 65(3-4): 61-63, 2016 Dec.
Article in English | MEDLINE | ID: mdl-29989721

ABSTRACT

Ganglioneuromas are rare benign tumors arising from neuroepithelial cells. Even more rarely they involve lumbar spinal nerve roots. We report a 34-year-old male patient who presented with typical lumbar radiculopathy. He had low back pain radiating to the right lower leg with numbness. His MRI revealed a herniated disc at L5-S1 compressing the right nerve root. Surgery was planned for microdiscectomy and nerve root decompression. Right L5 hemilaminotomy was performed and the nerve root was identified. Surprisingly the nerve root was markedly inflamed and there was no obvious disc tissue herniation. Considering it to be a spinal nerve root tumor, the dura of the nerve root was opened and nerve root mass exposed. Subtotal resection was performed. Biopsy showed Ganglioneuroma. The main purpose of this article is to report such a rare case and also to review the literature.


Subject(s)
Ganglioneuroma/diagnosis , Intervertebral Disc Displacement/diagnosis , Intervertebral Disc , Lumbar Vertebrae , Radiculopathy/diagnosis , Spinal Cord Neoplasms/diagnosis , Spinal Nerve Roots , Adult , Biopsy , Diagnosis, Differential , Diagnostic Errors , Ganglioneuroma/diagnostic imaging , Ganglioneuroma/pathology , Ganglioneuroma/surgery , Humans , Magnetic Resonance Imaging , Male , Predictive Value of Tests , Spinal Cord Neoplasms/diagnostic imaging , Spinal Cord Neoplasms/pathology , Spinal Cord Neoplasms/surgery , Spinal Nerve Roots/diagnostic imaging , Spinal Nerve Roots/pathology , Spinal Nerve Roots/surgery
10.
Lipids ; 48(2): 105-13, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23275078

ABSTRACT

The aim of the present study was to investigate the effect of sandalwood seed oil on fatty acid (FA) profiles and inflammatory factors in rats. Fifty male Sprague-Dawley rats were randomly divided into five different dietary groups: 10 % soybean oil (SO), 10 % olive oil (OO), 10 % safflower oil (SFO), 10 % linseed oil (LSO) and 8 % sandalwood seed oil blended with 2 % SO (SWSO) for 8 weeks. The SWSO group had a higher total n-3 polyunsaturated fatty acids (PUFA) levels but lower n-6:n-3 PUFA ratios in both adipose tissue and liver than those in the SO, OO and SFO groups (p < 0.05). Although the SWSO group had a much lower 18:3n-3 level (4.51 %) in their dietary lipids than the LSO group (58.88 %), the levels of docosahexaenoic acid (DHA: 22:6n-3) in liver lipids and phospholipids of the SWSO group (7.52 and 11.77 %) were comparable to those of the LSO group (7.07 and 13.16 %). Ximenynic acid, a predominant acetylenic FA in sandalwood seed oil, was found to be highly incorporated into adipose tissue (13.73 %), but relatively lower in liver (0.51 %) in the SWSO group. The levels of prostaglandin F(2α), prostaglandin E2, thromboxane B2, leukotriene B4, tumor necrosis factor-α and interleukin-1ß in both liver and plasma were positively correlated with the n-6:n-3 ratios, suggesting that increased n-6 PUFA appear to increase the formation of pro-inflammatory cytokines, whereas n-3 PUFA exhibit anti-inflammatory activity. The present results suggest that sandalwood seed oil could increase tissue levels of n-3 PUFA, DHA and reduce the n-6:n-3 ratio, and may increase the anti-inflammatory activity in rats.


Subject(s)
Cytokines/immunology , Eicosanoids/immunology , Fatty Acids/metabolism , Plant Oils/pharmacology , Santalum/chemistry , Sesquiterpenes/pharmacology , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Body Weight/drug effects , Cytokines/analysis , Cytokines/blood , Eicosanoids/analysis , Eicosanoids/blood , Fatty Acids/analysis , Fatty Acids, Omega-3/analysis , Fatty Acids, Omega-3/metabolism , Liver/drug effects , Liver/immunology , Liver/metabolism , Male , Oleic Acids/chemistry , Oleic Acids/pharmacology , Plant Oils/chemistry , Rats , Rats, Sprague-Dawley , Seeds/chemistry , Sesquiterpenes/chemistry
11.
J Allergy Clin Immunol ; 131(2): 461-7.e1-5, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23040887

ABSTRACT

BACKGROUND: Hypereosinophilic syndromes (HESs) are chronic disorders that require long-term therapy to suppress eosinophilia and clinical manifestations. Corticosteroids are usually effective, yet many patients become corticosteroid refractory or develop corticosteroid toxicity. Mepolizumab, a humanized monoclonal anti-IL-5 antibody, showed corticosteroid-sparing effects in a double-blind, placebo-controlled study of FIP1L1/PDGFRA-negative, corticosteroid-responsive subjects with HESs. OBJECTIVE: We evaluated long-term safety and efficacy of mepolizumab (750 mg) in HES. METHODS: MHE100901 is an open-label extension study. The primary end point was the frequency of adverse events (AEs). Optimal dosing frequency, corticosteroid-sparing effect of mepolizumab, and development of antimepolizumab antibodies were also explored. RESULTS: Seventy-eight subjects received 1 to 66 mepolizumab infusions each (including mepolizumab infusions received in the placebo-controlled trial). Mean exposure was 251 weeks (range, 4-302 weeks). The most common dosing interval was 9 to 12 weeks. The incidence of AEs was 932 events per 100 subject-years in the first year, declining to 461 events per 100 subject-years after 48 months. Serious AEs, including 1 death, were reported by the investigator as possibly due to mepolizumab in 3 subjects. The median daily prednisone dose decreased from 20.0 to 0 mg in the first 24 weeks. The median average daily dose for all subjects over the course of the study was 1.8 mg. Sixty-two percent of subjects were prednisone free without other HES medications for ≥ 12 consecutive weeks. No neutralizing antibodies were detected. Twenty-four subjects withdrew before study completion for death (n = 4), lack of efficacy (n = 6), or other reasons. CONCLUSION: Mepolizumab was well tolerated and effective as a long-term corticosteroid-sparing agent in PDGFRA-negative HES.


Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Antibodies, Monoclonal, Humanized/therapeutic use , Hypereosinophilic Syndrome/drug therapy , Adolescent , Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Antibodies, Monoclonal, Humanized/immunology , Double-Blind Method , Eosinophilia/drug therapy , Eosinophilia/immunology , Female , Humans , Hypereosinophilic Syndrome/immunology , Male , Middle Aged , Time , Young Adult
12.
Curr Med Res Opin ; 26(8): 1933-46, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20565230

ABSTRACT

BACKGROUND: Patients with hypereosinophilic syndrome (HES) vary considerably in their clinical presentation with regard to the severity and pattern of end-organ involvement. Clinical manifestations range from nonspecific symptoms to life-threatening, multisystem damage caused by eosinophil infiltration and local release of proinflammatory mediators and toxic granule products from these invading cells. The primary objective of treatment is to reduce blood and tissue eosinophilia and prevent eosinophil-mediated tissue damage as safely as possible. Systemic corticosteroids, such as prednisone, are first-line therapy for the management of patients with symptomatic HES who lack the Fip1-like 1-platelet-derived growth factor receptor-alpha (FIP1L1-PDGFRA) gene fusion mutation. The tyrosine kinase inhibitor, imatinib, is first-line treatment for FIP1L1-PDGFRA-positive patients). Because of the toxicity and serious side-effects that can occur with oral corticosteroids, alternative therapies may need to be introduced to reduce the cumulative corticosteroid exposure while maintaining disease control. SCOPE: Among corticosteroid-sparing agents are cytotoxic drugs and interferon-alpha; anti-interleukin-5 (IL-5) monoclonal antibodies are also currently under investigation for the treatment of HES. This manuscript reviews the available treatments for HES and the range of side-effects associated with long-term corticosteroid use, and then focuses on the anti-IL-5 monoclonal antibodies, mepolizumab and reslizumab. Of these, only mepolizumab has been studied in a randomized, placebo-controlled trial. Literature search methodology utilized www.pubmed.gov and www.clinicaltrials.gov with search terms including hypereosinophilic syndrome and corticosteroid side-effects coupled with search terms including eosinophils, mepolizumab and reslizumab through March 2010. FINDINGS: Three case studies are presented that demonstrate the limitations of corticosteroid therapy in terms of tolerability and quality of life, and the subsequent use of mepolizumab as a corticosteroid-sparing agent in these individuals. CONCLUSION: Targeted eosinophil-directed therapy with an anti-IL-5 neutralizing monoclonal antibody reduced the need for corticosteroids in these three HES patients without disease exacerbations.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Hypereosinophilic Syndrome/drug therapy , Hypereosinophilic Syndrome/immunology , Interleukin-5/antagonists & inhibitors , Adrenal Cortex Hormones/therapeutic use , Aged , Antibodies, Monoclonal, Humanized , Benzamides , Humans , Imatinib Mesylate , Interleukin-5/immunology , Male , Middle Aged , Piperazines/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use
14.
Metabolism ; 58(12): 1832-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19709696

ABSTRACT

Muscle glycogen exists as acid-insoluble (AIG) and acid-soluble (ASG) forms, with AIG levels reported in most recent studies in humans to be the most responsive to exercise and refeeding. Because the muscle samples in these studies were not homogenized to extract glycogen, such homogenization-free protocols might have resulted in a suboptimal yield of ASG. Our goal, therefore, was to determine whether similar findings can be achieved using homogenized muscle samples by comparing the effect of exercise and refeeding on ASG and AIG levels. Eight male participants cycled for 60 minutes at 70% Vo(2peak) before ingesting 10.9 +/- 0.6 g carbohydrate per kilogram body mass over 24 hours. Muscle biopsies were taken before exercise and after 0, 2, and 24 hours of recovery. Using a homogenization-dependent protocol to extract glycogen, 77% to 91% of it was extracted as ASG, compared with 11% to 24% with a homogenization-free protocol. In response to exercise, muscle glycogen levels fell from 366 +/- 24 to 184 +/- 46 mmol/kg dry weight and returned to 232 +/- 32 and 503 +/- 59 mmol/kg dry weight after 2 and 24 hours, respectively. Acid-soluble glycogen but not AIG accounted for all the changes in total glycogen during exercise and refeeding when extracted using a homogenization-dependent protocol, but AIG was the most responsive fraction when extracted using a homogenization-free protocol. In conclusion, the patterns of response of ASG and AIG levels to changes in glycogen concentrations in human muscles are highly dependent on the protocol used to acid-extract glycogen, with the physiologic significance of the many previous studies on AIG and ASG being in need of revision.


Subject(s)
Eating/physiology , Exercise/physiology , Glycogen/metabolism , Muscle, Skeletal/metabolism , Anaerobic Threshold/physiology , Female , Glycogen/chemistry , Glycogen/isolation & purification , Humans , Linear Models , Male , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...